Abstract:In this study, genes associated with the Notch signaling pathway in gliomas were analyzed using bioinformatics and in vitro experiments. The dataset GSE22772 was downloaded from the Gene-Cloud of Biotechnology Information database. Differentially expressed genes (DEGs) between short hairpin RNA (shRNA) intervening glioma cells and control cells were screened using the unpaired t test. Functional enrichment analysis was performed, and coexpression network was analyzed to identify the most important genes associated with the Notch signaling pathway. Integrin beta 1 (ITGB1) mRNA and protein levels in clinical glioma tumor samples and tumor adjacent normal tissue samples were analyzed using quantitative real-time PCR and immunohistochemistry, respectively. The relationship between ITGB1 expression and the prognosis of patients with gliomas was analyzed using the Kaplan-Meier curve. ITGB1 interference expression cell line U87 and ITGB1 overexpressing cell line were established using sh-ITGB1 and oe-ITGB1 plasmids, respectively. MTT and colony formation assays were used to detect changes in the proliferation of glioma cells. Moreover, western blotting was used to detect the expression of Notch and Hey1. A total of 7,962 DEGs were screened between shRNA intervening glioma cells and control cells, which were mainly associated with spliceosome, proteoglycans in cancer, focal adhesion, and the Notch signaling pathway. ITGB1 showed the highest expression in the coexpression network. The mRNA and protein expression of ITGB1 in glioma tumor samples was significantly higher than that in tumor adjacent normal tissue samples ( p < 0.05 ). Overall survival time of patients in the ITGB1 low-expression group was significantly longer than that in the ITGB1 high-expression group, indicating that ITGB1 expression negatively correlated with the prognosis. Fluorescence microscopy, qRT-PCR, and western blotting confirmed the transfection efficiency of ITGB1 overexpression and interference expression in U251 and U87 cells. The MTT and colony formation assays indicated that U87 cell proliferation was significantly inhibited after intervention with ITGB1 ( p < 0.05 ), and overexpression of ITGB1 significantly promoted U251 cell proliferation ( p < 0.05 ). In addition, the expression of Notch and Hey1 proteins was significantly decreased after ITGB1 intervention ( p < 0.05 ), and their expression was significantly upregulated after ITGB1 overexpression ( p < 0.05 ). ITGB1 expression in glioma tissues was significantly higher than that in adjacent normal tissues and was negatively correlated with the survival time of patients. Therefore, ITGB1 can significantly promote proliferation of glioma cells via feedback regulation of the Notch signaling pathway.

GOLM1 Silencing Inhibits the Proliferation and Motility of Human Glioblastoma Cells Via the Wnt/β-catenin Signaling Pathway.

Hmga2 Sustains Self-Renewal and Invasiveness of Glioma-Initiating Cells

PDGFA/PDGFRα-regulated GOLM1 Promotes Human Glioma Progression Through Activation of AKT

GOLM1 Facilitates Human Colorectal Cancer Progression and Metastasis Via Activating the AKT/GSK3β/EMT Axis.

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

Sohlh1 Suppresses Glioblastoma Cell Proliferation, Migration, and Invasion by Inhibition of Wnt/β‐catenin Signaling

Role of Glycosyltransferase PomGnT1 in Glioblastoma Progression.

Knockdown of HMGB1 Improves Apoptosis and Suppresses Proliferation and Invasion of Glioma Cells.

Suppression of PTTG1 Inhibits Cell Angiogenesis, Migration and Invasion in Glioma Cells

Integrated Analysis Reveals Prognostic Value and Mesenchymal Identity Suppression by Glycoprotein M6B in Glioma.

Impact of Nuclear Peripheral Chromatin Lamin LMNB1 Gene in the Proliferation and Migration of Glioma Cells

Silencing GMPPB Inhibits the Proliferation and Invasion of GBM via Hippo/MMP3 Pathways

Depletion of Thymopoietin Inhibits Proliferation and Induces Cell Cycle Arrest/apoptosis in Glioblastoma Cells

Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells Via Suppression of Wnt/β-Catenin Pathway

TMBIM1 Promotes Proliferation and Attenuates Apoptosis in Glioblastoma Cells by Targeting the P38 MAPK Signalling Pathway.

Overexpression of GBP1 Predicts Poor Prognosis and Promotes Tumor Growth in Human Glioblastoma Multiforme.

GGNBP2 Suppresses the Proliferation, Invasion, and Migration of Human Glioma Cells.

SECTM1 Promotes the Development of Glioblastoma and Mesenchymal Transition by Regulating the TGFβ1/Smad Signaling Pathway.

Integrin Beta 1 Promotes Glioma Cell Proliferation by Negatively Regulating the Notch Pathway

Knockdown of Immature Colon Carcinoma Transcript-1 Inhibits Proliferation of Glioblastoma Multiforme Cells Through Gap 2/mitotic Phase Arrest

Transcription factor YY1-activated GNG5 facilitates glioblastoma cell growth, invasion, stemness and glycolysis through Wnt/β-catenin pathway